(Q33490474)

English

Weekly gemcitabine in advanced or metastatic solid tumors. A clinical phase I study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Weekly gemcitabine in advanced or metastatic solid tumors. A clinical phase I study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

C F Pollera

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A Ceribelli

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

M Crecco

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

F Calabresi

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

111-119

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Action of 2',2'-difluorodeoxycytidine on DNA synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The calculation of received dose intensity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00874440

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33490474&oldid=2195410220"